US 12139546
Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
granted A61KA61K2039/505A61K31/7088
Quick answer
US patent 12139546 (Methods of treating urea cycle disorders by interfering with glucagon receptor signaling) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K31/7088, A61K45/06, A61P